Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

LL-95509 exhibits optimum activity against GARFT

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Shanghai Institute of Materia Medica reveals epibatidine analogue

May 31, 1996

5-HT4 antagonist LY-353433: Potential treatment for GI disorders

May 24, 1996

Glaxo Wellcome's new dihydrofolate reductase inhibitor 195U89

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Anti-HIV compounds isolated from marine organism

May 24, 1996

Excellent anti-HIV exhibited by RD4-2217

May 24, 1996

Oral anti-HIV oligosaccharide sulfate derivative presented at antiviral congress

May 24, 1996

Anti-HIV-1 activity demonstrated in mice by RKS-1443

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...